github link
Accession IconGSE65095

FinHER trial : Patients with human epidermal growth factor receptor 2 (HER2)positive breast cancer

Organism Icon Homo sapiens
Sample Icon 203 Downloadable Samples
Technology Badge Icon Affymetrix Human Genome U219 Array (hgu219)

Submitter Supplied Information

Description
The FinHER trial is a multicentre phase 3 randomised adjuvant breast cancer trial that enrolled 1010 patients. The women were randomly assigned to receive three cycles of docetaxel or vinorelbine, followed by three cycles of fluorouracil, epirubicin, and cyclophosphamide.
PubMed ID
Total Samples
203
Submitter’s Institution

Samples

Show of 0 Total Samples
Filter
Add/Remove
Accession Code
Title
Age
Disease stage
Processing Information
Additional Metadata
No rows found
Loading...